Summary: Featuring articles on dual antiplatelet treatment after minor stroke, effects of L-glutamine on sickle cell-related pain, procalcitonin in the treatment of acute respiratory illness, five-year outcomes with FFR-guided PCI, Medicare's bundled payments for medical conditions, and clonal hematopoiesis and hematologic cancer; a review article on psychosis; a case report of a man with leg weakness, recurrent falls, and anemia; and Perspective articles on the FDA and the next wave of drug abuse, on turning the tables, on Twitter tailwinds, and on the inevitable math behind entitlement reform.
